XT
MEDP icon

XTX Topco’s Medpace MEDP Stock Holding History

XTX Topco’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$302K Sell
571
-3,145
-85% -$1.45M ﹤0.01% 2919
2026
Q1 		$1.78M Buy
+3,716
New +$1.9M 0.03% 917
2025
Q3 		– Sell
-1,009
Closed -$317K – 2990
2025
Q2 		$317K Sell
1,009
-5,327
-84% -$1.6M 0.01% 1391
2025
Q1 		$1.93M Buy
6,336
+2,614
+70% +$879K 0.1% 273
2024
Q4 		$1.24M Sell
3,722
-2,818
-43% -$956K 0.1% 198
2024
Q3 		$2.18M Buy
6,540
+5,573
+576% +$2.12M 0.16% 128
2024
Q2 		$398K Sell
967
-372
-28% -$147K 0.03% 786
2024
Q1 		$541K Buy
+1,339
New +$471K 0.07% 446
2023
Q4 		– Sell
-1,717
Closed -$416K – 1893
2023
Q3 		$416K Buy
+1,717
New +$439K 0.07% 508
2023
Q2 		– Sell
-1,904
Closed -$358K – 1653
2023
Q1 		$358K Buy
+1,904
New +$394K 0.08% 511
2022
Q4 		– Sell
-1,762
Closed -$277K – 1349
2022
Q3 		$277K Buy
+1,762
New +$281K 0.07% 562
2021
Q3 		– Sell
-1,719
Closed -$304K – 908
2021
Q2 		$304K Buy
+1,719
New +$297K 0.1% 357

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

XTX Topco's MEDP Position: Q2 2026 in Review

XTX Topco reduced its Medpace (MEDP) stake by 85% in Q2 2026, selling an estimated $1.45M and leaving 571 shares worth $302K. The position accounts for ﹤0.01% of the portfolio, ranked #2919.

XTX Topco first reported a position in MEDP in Q2 2021 and has held it in 12 quarters since. The position peaked at $2.18M in Q3 2024. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • XTX Topco held 571 shares of Medpace worth $302K as of Q2 2026.
  • XTX Topco sold 3,145 Medpace shares in Q2 2026, an estimated $1.45M.
  • Medpace made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #2919 holding.
  • XTX Topco first reported a position in Medpace in Q2 2021 and has held it in 12 quarters since.
  • XTX Topco's Medpace position peaked at $2.18M in Q3 2024.
  • 699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.